ARTICLE AD BOX
![]()
NEW DELHI: Access to quitting immunodeficiency similar nicotine gums and lozenges whitethorn soon beryllium tightened, raising concerns among experts it could go harder for smokers to quit. The trigger is simply a proposal by the Drug Technical Advisory Board (DTAB) to restrict over-the-counter (OTC) entree to astir nicotine replacement products.
The connection exempts lone unflavoured 2-mg nicotine gum and excludes nicotine lozenges (2 mg).
Currently, immoderate of these products are disposable without a licence. The projected changes could mean less options and much hurdles for those trying to quit. Experts accidental the concerns stem from however addiction works. Nicotine - not the enactment of smoking - is an addictive substance, and withdrawal symptoms often propulsion users backmost to cigarettes. Nicotine replacement therapies - gums and lozenges - assistance negociate the symptoms by delivering nicotine without the thousands of harmful chemicals successful baccy smoking that origin cancer and bosom disease. But they are not a guaranteed solution. India, with implicit 1.35 cardinal tobacco-related deaths annually, depends heavy connected accessible enactment for quitting.
Experts pass adjacent tiny barriers tin discourage specified attempts. The committee has projected safeguards, including a prohibition connected merchantability to minors. Some experts reason the hazard of misuse of nicotine replacement immunodeficiency whitethorn beryllium overstated. Pulmonologist Dr Priyanka Chaudhary Bindroo said, "... Restricting a WHO-approved cessation assistance without modern grounds is simply a measurement backward."
